Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D72UDH
|
|||
| Drug Name |
OXB-102
|
|||
| Synonyms |
AXO-Lenti-PD
Click to Show/Hide
|
|||
| Drug Type |
Gene therapy
|
|||
| Indication | Parkinson disease [ICD-11: 8A00.0; ICD-10: F02.3, G20; ICD-9: 332] | Phase 1/2 | [1] | |
| Company |
Oxford BioMedica; Axovant Sciences
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03720418) Study of OXB-102 (AXO-Lenti-PD) in Patients With Bilateral, Idiopathic Parkinson's Disease (SUNRISE-PD). U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of Oxford BioMedica. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.